Lyka Labs · NSE: LYKALABS · BSE: 500259
Q2 FY21 results · Jul–Sep 2020
Lyka Labs reported revenue from operations of ₹17.46 crore (up 28.1% from Q2 FY20) and net loss of ₹5.72 crore for Q2 FY21 (Jul–Sep 2020), on a consolidated basis.
| Item | Q2 FY21 | Q2 FY20 | YoY | Q1 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 17.46 | 13.62 | +28.1% | 17.72 | −1.5% |
| Other income | 0.36 | 0.35 | +3.3% | 0.36 | +1.0% |
| Total income | 17.82 | 13.97 | +27.5% | 18.08 | −1.4% |
| Profit before tax | (5.36) | (3.85) | Loss widened | (4.14) | Loss widened |
| Net profit for the period | (5.72) | (3.20) | Loss widened | (4.09) | Loss widened |
| EPS, basic (₹) | (2.01) | (1.14) | Loss widened | (1.64) | Loss widened |
| Net margin (%) | -32.8 | -23.5 | -23.1 |
| Item | Q2 FY21 | Q2 FY20 | YoY | Q1 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 12.10 | 8.30 | +45.8% | 10.50 | +15.3% |
| Other income | 0.44 | 0.39 | +13.3% | 0.47 | −5.8% |
| Total income | 12.55 | 8.69 | +44.3% | 10.97 | +14.3% |
| Profit before tax | (5.17) | (1.10) | Loss widened | (5.78) | Loss narrowed |
| Net profit for the period | (5.13) | (1.20) | Loss widened | (5.72) | Loss narrowed |
| EPS, basic (₹) | (1.80) | (0.43) | Loss widened | (2.00) | Loss narrowed |
| Net margin (%) | -42.4 | -14.5 | -54.5 |
Consolidated
- Filed with BSE
- 09 Nov 2020, 18:14 IST
- Board meeting
- 06 Nov 2020
- Period
- 01 Jul 2020 to 30 Sep 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 09 Nov 2020, 18:14 IST
- Board meeting
- 06 Nov 2020
- Period
- 01 Jul 2020 to 30 Sep 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE